The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Design of the EFECTS Trial
Official Title: Design of the EFECTS Trial, Investigating the Influence of Postoperative Enteral Feeding in Esophageal Cancer paTients on Survival
Study ID: NCT02017366
Brief Summary: It is well known that there is a considerable postoperative weight loss in patients undergoing esophageal resection for cancer. We believe that this weigh loss can be limited by administering postoperative enteral feeding (target: 1000 kCal/ day) via feeding jejunostomy for at least 6 weeks postoperatively. We hypothesize that patients undergoing esophageal resection for cancer will have a better overall survival with postoperative additional enteral feeding than when on regular oral diet alone.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
University hospital Leuven, Leuven, Vl-Brabant, Belgium
Name: Hans Van Veer, MD
Affiliation: Universitaire Ziekenhuizen KU Leuven
Role: PRINCIPAL_INVESTIGATOR
Name: Philippe Nafteux, MD
Affiliation: Universitaire Ziekenhuizen KU Leuven
Role: STUDY_CHAIR
Name: Willy Coosemans, MD, PhD
Affiliation: Universitaire Ziekenhuizen KU Leuven
Role: STUDY_CHAIR
Name: Johnny Moons, MScN
Affiliation: Universitaire Ziekenhuizen KU Leuven
Role: STUDY_CHAIR
Name: Paul De Leyn, MD, PhD
Affiliation: Universitaire Ziekenhuizen KU Leuven
Role: STUDY_DIRECTOR